Abstract
Background
Despite the advances in antihypertensive therapy and renal revascularization, there
remains a group of patients in whom renovascular disease leads to renal atrophy and
treatment-resistant hypertension.
Methods
We performed an observational cohort study in which we reviewed blood pressures, renal
function, and predictors of response in 74 patients who underwent nephrectomy of a
small kidney for uncontrolled hypertension between 1990 and 2000.
Results
The median age of the patients was 65 years; 43 (58%) were women. Thirty-five patients
(47%) underwent nephrectomy as part of combined revascularization of the contralateral
kidney. Associated atherosclerotic diseases were common (28% to 49%), as were prior
renal revascularization (21 [28%]) and hypertensive urgency/emergencies (23 [31%]).
The mean (± SD) long axis of the affected kidney was 8 ± 2 cm, and the mean function
of the kidney (based on radioisotope renography) was 12% ± 11% of total renal function.
The average systolic blood pressure fell from 168 ± 19 mm Hg to 136 ± 18 mm Hg (P <0.0001) and diastolic blood pressure declined from 88 ± 10 mm Hg to 76 ± 9 mm Hg
(P <0.0001) at the most recent available clinic visit (mean follow-up, 4.1 ± 2.6 years).
In addition, the number of antihypertensive medications decreased from 3.2 ± 1.1 to
2.2 ± 1.5 (P <0.0001). Renal function remained stable. Results were similar (preoperative blood
pressure of 165/88 mm Hg taking three medications to 137/77 mm Hg taking two medications)
among the 39 patients who had a nephrectomy without contralateral revascularization.
Conclusion
Our results suggest that in selected patients with resistant hypertension and renal
artery disease that has resulted in atrophic kidneys with reduced function, nephrectomy
can improve blood pressure control without further loss in overall renal function.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Medical therapy for renovascular hypertension.Am J Hypertens. 1988; 1: 338S-343S
- ACE inhibitors in renovascular hypertension.Cardiovasc Drug Ther. 1990; 4: 229-235
- Risk of atrophy in kidneys with atherosclerotic renal artery stenosis.Kidney Int. 1998; 53: 735-742
- Prospective studies of diagnosis and intervention.Semin Nephrol. 2000; 20: 463-473
- Renal artery stenosis.Annu Rev Med. 2001; 52: 421-442
- Renal artery stenosis.N Engl J Med. 2001; 344: 431-442
- Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-hypertension).Lancet. 1991; 338: 1281-1285
- Medical research council trial of treatment of hypertension in older adults.BMJ. 1992; 304: 405-412
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) trial investigators.Lancet. 1997; 350: 757-764
- Advanced renovascular hypertension and renal insufficiency.J Vasc Surg. 1995; 21: 750-760
- Renal artery angioplasty.Mayo Clinic Proc. 1995; 70: 1041-1052
The Sixth Report of the National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health; 1997. Publication 98-4080
- Prediction of creatinine clearance from serum creatinine.Nephron. 1976; 16: 31-41
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 976;58:259–:263.
- Chronic pyelonephritis and arterial hypertension.J Clin Invest. 1937; 16: 889-897
- Atrophic pyelonephritis versus congenital renal hypoplasia.JAMA. 1952; 148: 1470-1477
- Outcomes of atherosclerotic renal artery stenosis managed without revascularization.Mayo Clin Proc. 2000; 75: 437-444
- Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis.Circulation. 1998; 98: 642-647
- Hand assisted laparoscopic donor nephrectomy.J Urol. 2001; 166: 444-448
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension.Lancet. 1998; 351: 1755-1762
- Predictors of the progression of renal disease in the modification of diet in renal disease study.Kidney Int. 1997; 51: 1908-1919
- Chronic renal artery occlusion.J Vasc Surg. 1999; 29: 140-149
- Diagnosis of renovascular hypertension.in: Marins R.G. Controversies in Nephrology and Hypertension. Churchill Livingstone, New York, NY1984: 109-122
Article info
Publication history
Accepted:
February 11,
2003
Received:
June 25,
2002
Identification
Copyright
© 2003 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
